Skip to main content
NCBI home page
Gut logoLink to Gut
. 1985 Nov;26(11):1214–1219. doi: 10.1136/gut.26.11.1214

Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis.

I Bjarnason, M N Marsh, A Price, A J Levi, T J Peters
PMCID: PMC1432901  PMID: 3934051

Abstract

Intestinal permeability was investigated in patients with coeliac disease and dermatitis herpetiformis by a 51Chromium-labelled ethylenediaminetetraacetate (51Cr-EDTA) absorption test and the results correlated with histomorphometric analysis and intraepithelial lymphocyte counts of jejunal biopsies. The mean (+/- SD) 24 hour urine excretion of 51Cr-EDTA in 34 healthy volunteers was 1.9 +/- 0.5% of the orally administered test dose. Patients with untreated coeliac disease (19) or untreated dermatitis herpetiformis (five) excreted significantly more 51Cr-EDTA than controls (5.9 +/- 2.7% and 4.6 +/- 2.1%, respectively, p less than 0.001) and all were outside the normal range of 1.0-2.6%. Patients with coeliac disease (42) treated for 6 months-23 years (mean 5 years) and patients with dermatitis herpetiformis (11) treated for 6 months-8 years (mean 3 years) excreted significantly more 51Cr-EDTA than controls, 4.2 +/- 2.4% p less than 0.0001 and 3.0 +/- 0.9% p less than 0.003 respectively. Eleven of 14 (79%) treated patients with coeliac disease with an entirely normal jejunal mucosae demonstrated abnormal intestinal permeability. Intestinal permeability did not correlate significantly with either the mucosal height/crypt depth ratio or intraepithelial lymphocyte counts in jejunal biopsies from patients with untreated or treated coeliac disease. The demonstration of a persistent increase in intestinal permeability in patients with both coeliac disease and dermatitis herpetiformis may suggest a common pathogenetic mechanism in both disorders. It is postulated that altered permeability may facilitate the entry of gluten or a fraction thereof into the lamina propria where it causes a cascade of immunological events.

Full text

PDF
1214

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrens F. A., Aronson A. L. A comparative study of the toxic effects of calcium and chromium chelates of ethylenediaminetetraacetate in the dog. Toxicol Appl Pharmacol. 1971 Jan;18(1):10–25. doi: 10.1016/0041-008x(71)90310-3. [DOI] [PubMed] [Google Scholar]
  2. Aronson A. L., Rogerson K. M. Effect of calcium and chromium chelates of ethylenediaminetetraacetate on intestinal permeability and collagen metabolism in the rat. Toxicol Appl Pharmacol. 1972 Apr;21(4):440–453. doi: 10.1016/0041-008x(72)90002-6. [DOI] [PubMed] [Google Scholar]
  3. Atherton D. J. Allergy and atopic eczema II. Clin Exp Dermatol. 1981 May;6(3):317–325. doi: 10.1111/j.1365-2230.1981.tb02311.x. [DOI] [PubMed] [Google Scholar]
  4. Bjarnason I., Goolamali S. K., Levi A. J., Peters T. J. Intestinal permeability in patients with atopic eczema. Br J Dermatol. 1985 Mar;112(3):291–297. doi: 10.1111/j.1365-2133.1985.tb04856.x. [DOI] [PubMed] [Google Scholar]
  5. Bjarnason I., Peters T. J. In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease. Gut. 1984 Feb;25(2):145–150. doi: 10.1136/gut.25.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bjarnason I., Peters T. J., Veall N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet. 1983 Feb 12;1(8320):323–325. doi: 10.1016/s0140-6736(83)91628-8. [DOI] [PubMed] [Google Scholar]
  7. Bjarnason I., Peters T. J., Wise R. J. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1984 Jan 28;1(8370):179–182. doi: 10.1016/s0140-6736(84)92109-3. [DOI] [PubMed] [Google Scholar]
  8. Bjarnason I., Smethurst P., Levi A. J., Peters T. J. Intestinal permeability to 51Cr-EDTA in rats with experimentally induced enteropathy. Gut. 1985 Jun;26(6):579–585. doi: 10.1136/gut.26.6.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ecknauer R., Buck B., Breitig D. An experimental model for measuring intestinal permeability. Digestion. 1983;26(1):24–32. doi: 10.1159/000198865. [DOI] [PubMed] [Google Scholar]
  10. Fiasse R., Lurhuma A. Z., Cambiaso C. L., Masson P. L., Dive C. Circulating immune complexes and disease activity in Crohn's disease. Gut. 1978 Jul;19(7):611–617. doi: 10.1136/gut.19.7.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fry L., Keir P., McMinn R. M., Cowan J. D., Hoffbrand A. V. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet. 1967 Oct 7;2(7519):729–733. doi: 10.1016/s0140-6736(67)91942-3. [DOI] [PubMed] [Google Scholar]
  12. Gawkrodger D. J., Blackwell J. N., Gilmour H. M., Rifkind E. A., Heading R. C., Barnetson R. S. Dermatitis herpetiformis: diagnosis, diet and demography. Gut. 1984 Feb;25(2):151–157. doi: 10.1136/gut.25.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hamilton I., Cobden I., Rothwell J., Axon A. T. Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut. 1982 Mar;23(3):202–210. doi: 10.1136/gut.23.3.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jewell D. P., Maclennan I. C., Truelove S. C. Circulating immune complexes in ulcerative colitis and Crohn's disease. Gut. 1972 Oct;13(10):839–840. [PubMed] [Google Scholar]
  15. Laker M. F., Menzies I. S. Increase in human intestinal permeability following ingestion of hypertonic solutions. J Physiol. 1977 Mar;265(3):881–894. doi: 10.1113/jphysiol.1977.sp011750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lynn K. L., Shenkin A., Marshall R. D. Factors affecting excretion of human urinary Tamm-Horsfall glycoprotein. Clin Sci (Lond) 1982 Jan;62(1):21–26. doi: 10.1042/cs0620021. [DOI] [PubMed] [Google Scholar]
  17. Marsh M. N. Immunocytes, enterocytes and the lamina propria: an immunopathological framework of coeliac disease. J R Coll Physicians Lond. 1983 Oct;17(4):205–212. [PMC free article] [PubMed] [Google Scholar]
  18. McNicholl B., Egan-Mitchell B., Stevens F., Keane R., Baker S., McCarthy C. F., Fottrell P. F. Mucosal recovery in treated childhood celiac disease (gluten-sensitive enteropathy). J Pediatr. 1976 Sep;89(3):418–424. doi: 10.1016/s0022-3476(76)80539-2. [DOI] [PubMed] [Google Scholar]
  19. Menzies I. S., Laker M. F., Pounder R., Bull J., Heyer S., Wheeler P. G., Creamer B. Abnormal intestinal permeability to sugars in villous atrophy. Lancet. 1979 Nov 24;2(8152):1107–1109. doi: 10.1016/s0140-6736(79)92507-8. [DOI] [PubMed] [Google Scholar]
  20. Scott B. B., Losowsky M. S. Patchiness and duodenal-jejunal variation of the mucosal abnormality in coeliac disease and dermatitis herpetiformis. Gut. 1976 Dec;17(12):984–992. doi: 10.1136/gut.17.12.984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Slavin G., Sowter C., Robertson K., McDermott S., Paton K. Measurement in jejunal biopsies by computer-aided microscopy. J Clin Pathol. 1980 Mar;33(3):254–261. doi: 10.1136/jcp.33.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TIDBALL C. S. MAGNESIUM AND CALCIUM AS REGULATORS OF INTESTINAL PERMEABILITY. Am J Physiol. 1964 Jan;206:243–246. doi: 10.1152/ajplegacy.1964.206.1.243. [DOI] [PubMed] [Google Scholar]
  23. WARREN S., SOMMERS S. C. Pathology of regional ileitis and ulcerative colitis. J Am Med Assoc. 1954 Jan 16;154(3):189–193. doi: 10.1001/jama.1954.02940370001001. [DOI] [PubMed] [Google Scholar]
  24. Walker W. A. Antigen absorption from the small intestine and gastrointestinal disease. Pediatr Clin North Am. 1975 Nov;22(4):731–746. doi: 10.1016/s0031-3955(16)33204-7. [DOI] [PubMed] [Google Scholar]
  25. Walker W. A., Isselbacher K. J. Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology. 1974 Sep;67(3):531–550. [PubMed] [Google Scholar]
  26. Wands J. R., LaMont J. T., Mann E., Isselbacher K. J. Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med. 1976 Jan 15;294(3):121–124. doi: 10.1056/NEJM197601152940301. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES